Latest reported quarter: Q4, ended Jun 2026 · reported in ARS
Quarter 2026/FY
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
| Line item | 2026 ANNUAL (ARS) |
2026 Q4 (ARS) |
2026 Q3 (ARS) |
2026 Q2 (ARS) |
2026 Q1 (ARS) |
|---|---|---|---|---|---|
| Total Revenue as Reported | ARS 1.38T | ARS 413.85B | ARS 252.69B | ARS 307.50B | ARS 318.53B |
| Total Operating Revenue | ARS 1.38T | ARS 413.85B | ARS 252.69B | ARS 307.50B | ARS 318.53B |
| Cost of Revenue | ARS 841.21B | ARS 259.00B | ARS 134.70B | ARS 188.21B | ARS 204.35B |
| Gross Profit | ARS 538.16B | ARS 154.85B | ARS 117.98B | ARS 119.29B | ARS 114.18B |
| Operating Expense | ARS 304.11B | ARS 95.25B | ARS 72.13B | ARS 48.56B | ARS 53.26B |
| Selling and Admin Expenses | ARS 202.79B | ARS 65.83B | ARS 57.36B | ARS 58.23B | ARS 39.97B |
| -Selling & Marketing Expense | ARS 61.10B | ARS 22.81B | ARS 22.07B | ARS 25.16B | ARS 14.85B |
| -General & Admin Expense | ARS 141.70B | ARS 43.02B | ARS 35.29B | ARS 33.07B | ARS 25.12B |
| Depreciation & Amortization & Depletion | ARS 8.58B | ARS 2.74B | – | – | ARS 1.36B |
| -Depreciation & Amortization | ARS 8.58B | ARS 2.74B | – | – | ARS 1.36B |
| Other Taxes | ARS 44.21B | ARS 13.11B | – | – | ARS 10.14B |
| Other Operating Expenses | ARS 48.52B | ARS 16.26B | ARS 14.77B | -ARS 9.67B | ARS 1.79B |
| Operating Profit | ARS 234.04B | ARS 59.60B | ARS 45.85B | ARS 70.73B | ARS 60.91B |
| Net Non-Operating Interest Income (Expense) | -ARS 121.97B | -ARS 32.40B | ARS 129.59B | ARS 24.68B | -ARS 42.95B |
| Non-Operating Interest Income | ARS 22.77B | ARS 564.00M | ARS 4.85B | ARS 2.09B | ARS 4.29B |
| Non-Operating Interest Expense | ARS 156.48B | ARS 45.39B | ARS 45.49B | ARS 37.97B | ARS 39.10B |
| Total Other Finance Costs | -ARS 11.74B | -ARS 12.42B | -ARS 170.24B | -ARS 60.56B | ARS 8.13B |
| Other Income (Expense) | ARS 377.40B | ARS 139.40B | -ARS 160.62B | -ARS 19.78B | ARS 172.88B |
| Gain on Sale of Security | ARS 381.93B | ARS 168.37B | -ARS 170.70B | -ARS 49.84B | ARS 184.77B |
| Earnings from Equity Interest | ARS 39.45B | ARS 18.69B | ARS 9.30B | ARS 15.50B | -ARS 4.66B |
| Special Income (Charges) | -ARS 43.97B | -ARS 47.65B | ARS 782.00M | ARS 14.56B | -ARS 7.23B |
| -Less:Impairment of Capital Assets | ARS 21.59B | – | – | – | ARS 0.00 |
| -Less:Other Special Charges | ARS 6.55B | ARS 1.14B | – | -ARS 14.56B | ARS 6.33B |
| -Less:Write Off | ARS 4.55B | ARS 4.55B | – | – | ARS 904.00M |
| -Gain on Sale Of Business | ARS 0.00 | ARS 0.00 | – | – | ARS 0.00 |
| -Gain on Sale of Property/Plant/Equipment | -ARS 11.28B | -ARS 20.37B | ARS 782.00M | ARS 0.00 | ARS 6.00M |
| Pretax Profit | ARS 489.47B | ARS 166.61B | ARS 14.83B | ARS 75.63B | ARS 190.84B |
| Tax | ARS 117.19B | ARS 25.63B | -ARS 4.24B | ARS 484.00M | ARS 80.71B |
| Net Profit | ARS 372.28B | ARS 140.97B | ARS 19.07B | ARS 75.14B | ARS 110.13B |
| Profit from Continuing Operations | ARS 372.28B | ARS 140.97B | ARS 19.07B | ARS 75.14B | ARS 110.13B |
| Minority Interests | ARS 195.02B | ARS 85.38B | -ARS 21.12B | ARS 40.44B | ARS 73.29B |
| Net Income to Parent Company | ARS 177.26B | ARS 55.59B | ARS 40.19B | ARS 34.71B | ARS 36.84B |
| Net Income to Common Stockholders | ARS 177.26B | ARS 55.59B | ARS 40.19B | ARS 34.71B | ARS 36.84B |
| Basic EPS | ARS 2,696.80 | ARS 796.90 | ARS 627.60 | ARS 554.80 | ARS 588.09 |
| Diluted EPS | ARS 2,696.80 | ARS 796.90 | ARS 627.60 | ARS 513.70 | ARS 588.09 |
| Dividend Per Share | ARS 910.31 | ARS 0.00 | ARS 0.00 | ARS 910.31 | ARS 0.00 |
| Line item | 2026 ANNUAL (ARS) |
2026 Q4 (ARS) |
2026 Q3 (ARS) |
2026 Q2 (ARS) |
2026 Q1 (ARS) |
|---|---|---|---|---|---|
| Total Assets | ARS 7.24T | ARS 7.24T | ARS 6.51T | ARS 6.32T | ARS 5.84T |
| Total Current Assets | ARS 1.82T | ARS 1.82T | ARS 1.62T | ARS 1.59T | ARS 1.42T |
| Cash and Cash Equivalents & Short-Term Investments | ARS 789.38B | ARS 789.38B | ARS 657.02B | ARS 720.09B | ARS 620.12B |
| -Cash and Cash Equivalents | ARS 284.47B | ARS 284.47B | ARS 139.92B | ARS 434.77B | ARS 224.75B |
| -Short Term Investments | ARS 504.92B | ARS 504.92B | ARS 517.10B | ARS 285.32B | ARS 395.37B |
| Receivables | ARS 607.58B | ARS 607.58B | ARS 520.77B | ARS 461.46B | ARS 448.89B |
| -Accounts Receivable | ARS 605.85B | ARS 605.85B | ARS 519.77B | ARS 460.91B | ARS 448.27B |
| -Taxes Receivable | ARS 1.73B | ARS 1.73B | ARS 1.00B | ARS 546.00M | ARS 626.00M |
| Inventory | ARS 420.40B | ARS 420.40B | ARS 427.46B | ARS 393.45B | ARS 337.72B |
| Total Non-Current Assets | ARS 5.42T | ARS 5.42T | ARS 4.89T | ARS 4.73T | ARS 4.42T |
| Net PPE | ARS 1.10T | ARS 1.10T | ARS 1.06T | ARS 1.10T | ARS 966.77B |
| -Gross PPE | ARS 1.51T | ARS 1.51T | ARS 1.43T | ARS 1.44T | ARS 1.27T |
| -Accumulated Depreciation | -ARS 412.97B | -ARS 412.97B | -ARS 375.86B | -ARS 336.10B | -ARS 304.17B |
| Investments and Advances | ARS 306.23B | ARS 306.23B | ARS 280.70B | ARS 257.56B | ARS 229.65B |
| -Long Term Equity Investment | ARS 276.45B | ARS 276.45B | ARS 251.15B | ARS 221.58B | ARS 192.28B |
| Financial Assets | ARS 6.14B | ARS 6.14B | ARS 2.30B | ARS 2.00B | ARS 2.86B |
| Non Current Accounts Receivables | ARS 153.99B | ARS 153.99B | ARS 158.94B | ARS 202.39B | ARS 196.21B |
| Goodwill and Other Intangible Assets | ARS 41.44B | ARS 41.44B | ARS 35.02B | ARS 32.48B | ARS 30.45B |
| -Goodwill | ARS 13.04B | ARS 13.04B | ARS 8.29B | ARS 7.64B | ARS 7.12B |
| -Other Intangible Assets | ARS 28.40B | ARS 28.40B | ARS 26.72B | ARS 24.84B | ARS 23.33B |
| Non-Current Deferred Assets | ARS 24.22B | ARS 24.22B | ARS 18.46B | ARS 16.61B | ARS 14.13B |
| Other Non-Current Assets | ARS 69.97B | ARS 69.97B | ARS 67.71B | ARS 56.65B | ARS 53.11B |
| Total Liabilities | ARS 4.09T | ARS 4.09T | ARS 3.69T | ARS 3.71T | ARS 3.31T |
| Total Current Liabilities | ARS 1.25T | ARS 1.25T | ARS 1.13T | ARS 1.11T | ARS 1.07T |
| Payables | ARS 570.23B | ARS 570.23B | ARS 521.62B | ARS 489.23B | ARS 473.20B |
| -Accounts Payable | ARS 499.80B | ARS 499.80B | ARS 425.90B | ARS 434.37B | ARS 414.94B |
| -Total Tax Payable | ARS 70.43B | ARS 70.43B | ARS 95.73B | ARS 54.87B | ARS 58.26B |
| Current Accrued Expenses | ARS 51.26B | ARS 51.26B | ARS 40.57B | ARS 30.31B | ARS 40.48B |
| Short-Term Debt and Capital Lease Obligation | ARS 614.82B | ARS 614.82B | ARS 545.93B | ARS 582.80B | ARS 544.89B |
| -Current Debt | ARS 565.15B | ARS 565.15B | ARS 488.37B | ARS 533.49B | ARS 500.07B |
| -Current Capital Lease Obligation | ARS 49.68B | ARS 49.68B | ARS 57.56B | ARS 49.31B | ARS 44.82B |
| Current Provisions | ARS 6.06B | ARS 6.06B | ARS 5.87B | ARS 6.42B | ARS 4.65B |
| Other Current Liabilities | ARS 2.75B | ARS 2.75B | ARS 17.85B | ARS 3.69B | ARS 4.02B |
| Total Non-Current Liabilities | ARS 2.85T | ARS 2.85T | ARS 2.56T | ARS 2.60T | ARS 2.25T |
| Long Term Accounts Payable and Other Payables | ARS 77.40B | ARS 77.40B | ARS 69.16B | ARS 70.71B | ARS 94.75B |
| Non-Current Accrued Expenses | ARS 1.15B | ARS 1.15B | ARS 807.00M | ARS 466.00M | ARS 126.00M |
| Long Term Debt and Capital Lease Obligation | ARS 1.57T | ARS 1.57T | ARS 1.40T | ARS 1.46T | ARS 1.13T |
| -Long Term Debt | ARS 1.46T | ARS 1.46T | ARS 1.29T | ARS 1.35T | ARS 1.01T |
| -Long Term Capital Lease Obligation | ARS 111.48B | ARS 111.48B | ARS 110.50B | ARS 118.85B | ARS 118.39B |
| Derivative Product Liabilities | ARS 5.70B | ARS 5.70B | ARS 4.92B | ARS 3.61B | ARS 5.50B |
| Non-Current Liabilities | ARS 48.86B | ARS 48.86B | ARS 42.19B | ARS 47.58B | ARS 44.52B |
| Non-Current Deferred Liabilities | ARS 1.14T | ARS 1.14T | ARS 1.05T | ARS 1.01T | ARS 968.72B |
| Total Equity | ARS 3.15T | ARS 3.15T | ARS 2.81T | ARS 2.61T | ARS 2.53T |
| Stockholders' Equity | ARS 1.45T | ARS 1.45T | ARS 1.31T | ARS 1.10T | ARS 1.09T |
| Capital Stock | ARS 707.00M | ARS 707.00M | ARS 707.00M | ARS 647.00M | ARS 625.00M |
| -Common Stock | ARS 707.00M | ARS 707.00M | ARS 707.00M | ARS 647.00M | ARS 625.00M |
| Additional Paid-In Capital | ARS 498.59B | ARS 498.59B | ARS 467.00B | ARS 397.66B | ARS 366.88B |
| Retained Earnings | ARS 158.14B | ARS 158.14B | ARS 103.76B | ARS 58.09B | ARS 122.44B |
| Gains/Losses Not Affecting Retained Earnings | ARS 417.65B | ARS 417.65B | ARS 379.84B | ARS 305.25B | ARS 275.03B |
| Other Equity Interests | ARS 379.84B | ARS 379.84B | ARS 355.73B | ARS 341.99B | ARS 320.51B |
| Minority Interests | ARS 1.70T | ARS 1.70T | ARS 1.51T | ARS 1.50T | ARS 1.44T |
| Line item | 2026 ANNUAL (ARS) |
2026 Q4 (ARS) |
2026 Q3 (ARS) |
2026 Q2 (ARS) |
2026 Q1 (ARS) |
|---|---|---|---|---|---|
| Operating Cash Flow | ARS 62.94B | ARS 17.35B | -ARS 52.74B | -ARS 53.63B | ARS 151.97B |
| Net cash flow from continuing operations | ARS 0.00 | -ARS 45.59B | -ARS 52.74B | -ARS 53.63B | ARS 151.97B |
| Net Income from Continuing Operations | ARS 372.28B | ARS 140.97B | ARS 37.38B | ARS 83.80B | ARS 110.13B |
| Gain/Loss from Continuing Operations | -ARS 204.60B | -ARS 145.48B | ARS 127.48B | ARS 27.39B | -ARS 213.98B |
| Depreciation & Depletion & Amortization | ARS 23.90B | ARS 7.57B | ARS 6.60B | ARS 5.43B | ARS 4.31B |
| Deferred Tax | ARS 117.19B | ARS 25.63B | ARS 4.03B | ARS 6.83B | ARS 80.71B |
| Other Non-Cash Items | -ARS 64.54B | -ARS 49.32B | -ARS 80.24B | -ARS 47.10B | ARS 112.11B |
| Change in Working Capital | -ARS 130.89B | ARS 15.42B | -ARS 138.86B | -ARS 58.67B | ARS 51.22B |
| -Change in Inventory | -ARS 14.33B | ARS 61.99B | -ARS 128.22B | ARS 67.59B | -ARS 15.68B |
| -Change in Other Current Assets | -ARS 14.81B | – | – | -ARS 84.06B | ARS 41.88B |
| -Change in Other Current Liabilities | -ARS 34.78B | -ARS 19.11B | -ARS 25.81B | -ARS 9.63B | ARS 19.77B |
| -Change In Other Working Capital | -ARS 66.97B | -ARS 65.82B | ARS 13.31B | -ARS 13.25B | -ARS 1.21B |
| Net cash flow from investing | -ARS 306.52B | ARS 37.67B | -ARS 247.77B | ARS 62.40B | -ARS 158.81B |
| Net Cash Flow from Continuing Investing Activities | -ARS 294.54B | ARS 39.65B | -ARS 237.77B | ARS 62.40B | -ARS 158.81B |
| Net PPE Purchase and Sale | ARS 355.00M | ARS 8.45B | ARS 9.69B | -ARS 21.74B | ARS 3.95B |
| Net Intangibles Purchase and Sale | -ARS 2.53B | -ARS 841.00M | -ARS 834.00M | -ARS 513.00M | -ARS 340.00M |
| Net Business Purchase and Sale | -ARS 3.29B | ARS 5.07B | -ARS 721.00M | -ARS 1.00B | -ARS 6.63B |
| Net Investment Purchase and Sale | -ARS 272.79B | ARS 24.20B | -ARS 176.71B | ARS 40.41B | -ARS 160.69B |
| Net Other Investing Changes | -ARS 9.25B | ARS 227.00M | -ARS 9.52B | -ARS 132.00M | ARS 170.00M |
| Financing Cash Flow | ARS 189.64B | ARS 76.94B | -ARS 28.00B | ARS 179.89B | -ARS 39.19B |
| Net Cash Flow from Continuing Financing Activities | ARS 189.64B | -ARS 26.59B | ARS 75.53B | ARS 179.89B | -ARS 39.19B |
| Net Issuance Payments Of Debt | ARS 371.16B | ARS 102.46B | ARS 14.88B | ARS 273.86B | -ARS 20.04B |
| Net Common Stock Issuance | -ARS 28.00M | -ARS 28.00M | ARS 24.00M | -ARS 24.00M | ARS 0.00 |
| Cash Dividends Paid | -ARS 105.79B | -ARS 8.86B | -ARS 9.74B | -ARS 87.20B | ARS 0.00 |
| Proceeds from Stock Option Exercised | ARS 47.11B | ARS 3.61B | ARS 19.26B | ARS 10.41B | ARS 13.84B |
| Net Other Financing Charges | ARS 8.92B | ARS 111.47B | -ARS 106.02B | ARS 3.42B | ARS 51.00M |
| Ending Cash Balance | ARS 284.47B | ARS 284.47B | ARS 139.92B | ARS 434.77B | ARS 224.75B |
| Net Change in Cash | -ARS 53.94B | ARS 121.95B | -ARS 318.51B | ARS 188.65B | -ARS 46.04B |
| Beginning Cash Balance | ARS 335.01B | ARS 139.92B | ARS 434.77B | ARS 224.75B | ARS 265.83B |
| Free Cash Flow | ARS 5.93B | ARS 966.00M | -ARS 56.79B | -ARS 77.28B | ARS 139.03B |
| -Change in Payables and Accrued Expense | – | – | -ARS 66.18B | -ARS 19.33B | ARS 6.47B |
| Effect of Exchange Rate Changes | – | – | -ARS 679.00M | ARS 3.41B | ARS 1.76B |
No comments yet — be the first to weigh in on CRESY.